- Home
- PDSB vs GCTS Comparison
PDSB vs GCTS Comparison
Compare PDSB & GCTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PDSB
- GCTS
- Stock Information
- Founded
- PDSB 2005
- GCTS 1998
- Country
- PDSB United States
- GCTS United States
- Employees
- PDSB N/A
- GCTS N/A
- Industry
- PDSB Biotechnology: Pharmaceutical Preparations
- GCTS Blank Checks
- Sector
- PDSB Health Care
- GCTS Finance
- Exchange
- PDSB Nasdaq
- GCTS Nasdaq
- Market Cap
- PDSB 72.2M
- GCTS 82.5M
- IPO Year
- PDSB N/A
- GCTS N/A
- Fundamental
- Price
- PDSB $1.24
- GCTS $1.35
- Analyst Decision
- PDSB Strong Buy
- GCTS Strong Buy
- Analyst Count
- PDSB 2
- GCTS 1
- Target Price
- PDSB $10.00
- GCTS $5.00
- AVG Volume (30 Days)
- PDSB 473.1K
- GCTS 725.3K
- Earning Date
- PDSB 08-12-2025
- GCTS 08-13-2025
- Dividend Yield
- PDSB N/A
- GCTS N/A
- EPS Growth
- PDSB N/A
- GCTS N/A
- EPS
- PDSB N/A
- GCTS N/A
- Revenue
- PDSB N/A
- GCTS $6,359,000.00
- Revenue This Year
- PDSB N/A
- GCTS $133.55
- Revenue Next Year
- PDSB N/A
- GCTS $347.37
- P/E Ratio
- PDSB N/A
- GCTS N/A
- Revenue Growth
- PDSB N/A
- GCTS N/A
- 52 Week Low
- PDSB $0.85
- GCTS $0.90
- 52 Week High
- PDSB $4.42
- GCTS $5.38
- Technical
- Relative Strength Index (RSI)
- PDSB 39.29
- GCTS 51.20
- Support Level
- PDSB $1.20
- GCTS $1.26
- Resistance Level
- PDSB $1.40
- GCTS $1.49
- Average True Range (ATR)
- PDSB 0.10
- GCTS 0.11
- MACD
- PDSB -0.03
- GCTS -0.01
- Stochastic Oscillator
- PDSB 12.50
- GCTS 25.59
About PDSB PDS Biotechnology Corporation
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.
About GCTS GCT Semiconductor Holding Inc. Common Stock
GCT Semiconductor Holding Inc is a designer and supplier of 5G and 4G LTE semiconductor solutions. It enabled fast and reliable 4G LTE connectivity to numerous commercial devices such as CPEs, mobile hotspots, routers, M2M applications, and smartphones, etc. The system-on-chip solutions integrate radio frequency, baseband modem, and digital signal processing functions, therefore offering complete 4G and 5G platform solutions with small form factors, low power consumption, high performance, high reliability, and cost-effectiveness.